POTELLIGENTを利用した日本発,世界初の抗体医薬品 : 抗CCR4抗体モガムリズマブの研究開発経緯 (特集 新規がん治療薬の研究開発)

Icons representing 記事

POTELLIGENTを利用した日本発,世界初の抗体医薬品 : 抗CCR4抗体モガムリズマブの研究開発経緯(特集 新規がん治療薬の研究開発)

Call No. (NDL)
Z19-247
Bibliographic ID of National Diet Library
024930647
Material type
記事
Author
石井 俊彦
Publisher
東京 : 日本薬理学会
Publication date
2013-10
Material Format
Paper
Journal name
日本薬理学雑誌 = Folia pharmacologica Japonica : くすりとからだ : ファーマコロジカ 142(4)=751:2013.10
Publication Page
p.167-171
View All

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

  • CiNii Research

    Search Service
    Digital
    You can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Paper Digital

Material Type
記事
Author/Editor
石井 俊彦
Author Heading
Alternative Title
Development of an anti-CCR4 antibody, mogamulizumab, the first approved antibody made by POTELLIGENT technology
Periodical title
日本薬理学雑誌 = Folia pharmacologica Japonica : くすりとからだ : ファーマコロジカ
No. or year of volume/issue
142(4)=751:2013.10
Volume
142
Issue
4